The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Open accessAbstract
Background: The connection between uric acid (UA) and renal impairment is well known due to the urate capacity to precipitate within the tubules or extra-renal system. Emerging studies allege a new hypothesis concerning UA and renal impairment involving a pro-inflammatory status, endothelial dysfunction, and excessive activation of renin–angiotensin–aldosterone system (RAAS). Additionally, hyperuricemia associated with oxidative stress is incriminated in DNA damage, oxidations, inflammatory cytokine production, and even cell apoptosis. There is also increasing evidence regarding the association of hyperuricemia with chronic kidney disease (CKD), cardiovascular disease, and metabolic syndrome or diabetes mellitus. Conclusions: Important aspects need to be clarified regarding hyperuricemia predisposition to oxidative stress and its effects in order to initiate the proper treatment to determine the optimal maintenance of UA level, improving patients’ long-term prognosis and their quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of uric acid metabolism and excretion
Maiuolo, J., Oppedisano, F., Gratteri, S., Muscoli, C., & Mollace, V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.109 · Cited by 1,375
2020 American College of Rheumatology Guideline for the Management of Gout
FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., Gelber, A. C., Harrold, L. R., Khanna, D., King, C., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24180 · Cited by 983
Choi, H. K., Mount, D. B., & Reginato, A. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-7-200510040-00009 · Cited by 942
Kang, D.-H., Park, S.-K., Lee, I.-K., & Johnson, R. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050572 · Cited by 882
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Study, L. C., Köttgen, A., CARDIoGRAM Consortium, DIAGRAM Consortium, ICBP Consortium, MAGIC Consortium, Albrecht, E., Teumer, A., Vitart, V., Krumsiek, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2500 · Cited by 836
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
2020 American College of Rheumatology Guideline for the Management of Gout
FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., Gelber, A. C., Harrold, L. R., Khanna, D., King, C., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41247 · Cited by 810
Hyperuricemia and incident hypertension: A systematic review and meta‐analysis
Grayson, P. C., Kim, S. Y., LaValley, M., & Choi, H. K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20344 · Cited by 756
Corry, D. B., Eslami, P., Yamamoto, K., Nyby, M. D., Makino, H., & Tuck, M. L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f240bf · Cited by 751
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Woodward, O. M., Köttgen, A., Coresh, J., Boerwinkle, E., Guggino, W. B., & Köttgen, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901249106 · Cited by 688
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
Zhu, Y., Pandya, B. J., & Choi, H. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.033 · Cited by 655
Johnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
The Molecular Physiology of Uric Acid Homeostasis
Mandal, A. K., & Mount, D. B. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170343 · Cited by 550
Physiological functions and pathogenic potential of uric acid: A review
El Ridi, R., & Tallima, H. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.03.003 · Cited by 542
Rapa, S. F., Di Iorio, B. R., Campiglia, P., Heidland, A., & Marzocco, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010263 · Cited by 519
Serum uric acid and the risk of cardiovascular and renal disease
Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., & Mancia, G. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000701 · Cited by 463
Effect of insulin on uric acid excretion in humans
Quinones Galvan, A., Natali, A., Baldi, S., Frascerra, S., Sanna, G., Ciociaro, D., & Ferrannini, E. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.1.e1 · Cited by 451
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
Uric acid, hyperuricemia and vascular diseases
Jin, M. (2012) · Frontiers in Bioscience · doi:10.2741/3950 · Cited by 406
Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K. K., Ioannidis, P. A., Campbell, H., & Theodoratou, E. (2017) · BMJ · doi:10.1136/bmj.j2376 · Cited by 385
Lv, Q., Meng, X.-F., He, F.-F., Chen, S., Su, H., Xiong, J., Gao, P., Tian, X.-J., Liu, J.-S., Zhu, Z.-H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056864 · Cited by 364
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity
Furuhashi, M. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2020 · Cited by 361
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
Wang, J., Qin, T., Chen, J., Li, Y., Wang, L., Huang, H., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114259 · Cited by 341
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Joosten, L. A. B., Crişan, T. O., Bjornstad, P., & Johnson, R. J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0334-3 · Cited by 319
Hanna, R. M., Ghobry, L., Wassef, O., Rhee, C. M., & Kalantar-Zadeh, K. (2020) · Blood Purification · doi:10.1159/000504240 · Cited by 315
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Kimura, Y., Tsukui, D., & Kono, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212394 · Cited by 309
Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition
Yamanaka, H. (2011) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770.2011.596496 · Cited by 306
Uric Acid and Cardiovascular Events: A Mendelian Randomization Study
Kleber, M. E., Delgado, G., Grammer, T. B., Silbernagel, G., Huang, J., Krämer, B. K., Ritz, E., & März, W. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070660 · Cited by 299
Palmer, T. M., Nordestgaard, B. G., Benn, M., Tybjaerg-Hansen, A., Davey Smith, G., Lawlor, D. A., & Timpson, N. J. (2013) · BMJ · doi:10.1136/bmj.f4262 · Cited by 282
Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
Dekkers, C. C. J., Petrykiv, S., Laverman, G. D., Cherney, D. Z., Gansevoort, R. T., & Heerspink, H. J. L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13301 · Cited by 263
Major, T. J., Topless, R. K., Dalbeth, N., & Merriman, T. R. (2018) · BMJ · doi:10.1136/bmj.k3951 · Cited by 246
Homozygous SLC2A9 Mutations Cause Severe Renal Hypouricemia
Dinour, D., Gray, N. K., Campbell, S., Shu, X., Sawyer, L., Richardson, W., Rechavi, G., Amariglio, N., Ganon, L., Sela, B.-A., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040406 · Cited by 243
Choi, H. K., & Curhan, G. (2007) · Arthritis Care & Research · doi:10.1002/art.22762 · Cited by 240
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review
Caliceti, C., Calabria, D., Roda, A., & Cicero, A. (2017) · Nutrients · doi:10.3390/nu9040395 · Cited by 236
Research Advances in the Mechanisms of Hyperuricemia‐Induced Renal Injury
Su, H.-Y., Yang, C., Liang, D., & Liu, H.-F. (2020) · BioMed Research International · doi:10.1155/2020/5817348 · Cited by 226
Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers
Guthikonda, S., Sinkey, C., Barenz, T., & Haynes, W. G. (2003) · Circulation · doi:10.1161/01.cir.0000046448.26751.58 · Cited by 225
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
Bose, B., Badve, S. V., Hiremath, S. S., Boudville, N., Brown, F. G., Cass, A., de Zoysa, J. R., Fassett, R. G., Faull, R., Harris, D. C., et al. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft378 · Cited by 222
SGLT2 Inhibition in the Diabetic Kidney—From Mechanisms to Clinical Outcome
van Bommel, E. J. M., Muskiet, M. H. A., Tonneijck, L., Kramer, M. H. H., Nieuwdorp, M., & van Raalte, D. H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06080616 · Cited by 222
Arterial Stiffness in the Heart Disease of CKD
Zanoli, L., Lentini, P., Briet, M., Castellino, P., House, A. A., London, G. M., Malatino, L., McCullough, P. A., Mikhailidis, D. P., & Boutouyrie, P. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020117 · Cited by 211
Hyperuricemia-induced inflammasome and kidney diseases
Isaka, Y., Takabatake, Y., Takahashi, A., Saitoh, T., & Yoshimori, T. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv024 · Cited by 188
Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review
Tsai, C.-W., Lin, S.-Y., Kuo, C.-C., & Huang, C.-C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170393 · Cited by 183
Uric acid and the cardio‐renal effects of SGLT2 inhibitors
Bailey, C. J. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13670 · Cited by 183
Miao, Y., Ottenbros, S. A., Laverman, G. D., Brenner, B. M., Cooper, M. E., Parving, H.-H., Grobbee, D. E., Shahinfar, S., de Zeeuw, D., & Lambers Heerspink, H. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.171488 · Cited by 182
Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta‐Analysis
Agarwal, V., Hans, N., & Messerli, F. H. (2013) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00701.x · Cited by 173
Obesity and kidney stone disease: a systematic review
Carbone, A., Al Salhi, Y., Tasca, A., Palleschi, G., Fuschi, A., De Nunzio, C., Bozzini, G., Mazzaferro, S., & Pastore, A. L. (2018) · Minerva Urologica e Nefrologica · doi:10.23736/s0393-2249.18.03113-2 · Cited by 169
Shi, Y., Chen, W., Jalal, D., Li, Z., Chen, W., Mao, H., Yang, Q., Johnson, R. J., & Yu, X. (2012) · Kidney and Blood Pressure Research · doi:10.1159/000331453 · Cited by 166
Keenan, R. T. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.04.007 · Cited by 166
Jutabha, P., Anzai, N., Kitamura, K., Taniguchi, A., Kaneko, S., Yan, K., Yamada, H., Shimada, H., Kimura, T., Katada, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121301 · Cited by 159
Aktas, G., Khalid, A., Kurtkulagi, O., Duman, T. T., Bilgin, S., Kahveci, G., Atak Tel, B. M., Sincer, I., & Gunes, Y. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2039007 · Cited by 159
Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study
Lu, N., Dubreuil, M., Zhang, Y., Neogi, T., Rai, S. K., Ascherio, A., Hernán, M. Á., & Choi, H. K. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206917 · Cited by 157
Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review
Roumeliotis, S., Roumeliotis, A., Dounousi, E., Eleftheriadis, T., & Liakopoulos, V. (2019) · Nutrients · doi:10.3390/nu11081911 · Cited by 149
Relationship between oxidative stress and inflammation in hyperuricemia
Zhou, Y. L., Zhao, M., Pu, Z., Xu, G., & Xiang-kun, L. (2018) · Medicine · doi:10.1097/md.0000000000013108 · Cited by 134
Uric acid and plant-based nutrition
Jakše, B., Jakše, B., Pajek, M., & Pajek, J. (2019) · Nutrients · doi:10.3390/nu11081736 · Cited by 132
Renal effects of uric acid: hyperuricemia and hypouricemia
Park, J. H., Jo, Y. S., & Lee, J.-H. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.410 · Cited by 132
Wu, W., Dnyanmote, A. V., & Nigám, S. K. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070607 · Cited by 127
Renal Retention of Uric Acid Induced by Infusion of Beta-Hydroxybutyrate and Acetoacetate
Goldfinger, S. E., Klinenberg, J. R., Seegmiller, J. E., Miller, J. A., & Bradley, K. (1965) · New England Journal of Medicine · doi:10.1056/nejm196502182720705 · Cited by 126
Woodward, O. M., Tukaye, D. N., Cui, J., Greenwell, P., Constantoulakis, L. M., Parker, B. S., Rao, A., Köttgen, M., Maloney, P. C., & Guggino, W. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214530110 · Cited by 121
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
Giandalia, A., Giuffrida, A. E., Gembillo, G., Cucinotta, D., Squadrito, G., Santoro, D., & Russo, G. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115808 · Cited by 121
Liu, X., Zhai, T., Ma, R., Luo, C., Wang, H., & Liu, L. (2018) · Renal Failure · doi:10.1080/0886022x.2018.1456463 · Cited by 114
The systems biology of uric acid transporters: the role of remote sensing and signaling
Nigám, S. K., & Bhatnagar, V. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000427 · Cited by 112
Ejaz, A. A., Nakagawa, T., Kanbay, M., Kuwabara, M., Kumar, A., García‐Arroyo, F. E., Roncal-Jimenez, C. A., Sasai, F., Kang, D., Jensen, T., et al. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.12.004 · Cited by 104
Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease
Sampson, A. L., Singer, R. F., & Walters, G. D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009460.pub2 · Cited by 101
Bove, M., Cicero, A. F. G., Veronesi, M., & Borghi, C. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s115080 · Cited by 101
Serum Urate and the Risk of Parkinson's Disease: Results From a Meta-Analysis
Shen, C., Guo, Y. C., Luo, W. F., Chen, L., & Ding, M. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012981 · Cited by 100
Waheed, Y. A., Yang, F., & Sun, D. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.340 · Cited by 100
Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice
Gaubert, M., Bardin, T., Solal, A. C., Diévart, F., Fauvel, J., Guieu, R., Sadrin, S., Maixent, J. M., Galinier, M., & Paganelli, F. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114066 · Cited by 96
Ruggiero, C., Cherubini, A., Miller, E. R., Maggio, M. G., Najjar, S. S., Lauretani, F., Bandinelli, S., Senin, U., & Ferrucci, L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.02.065 · Cited by 94
Uric acid participating in female reproductive disorders: a review
Hu, J., Xu, W., Yang, H., & Mu, L. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00748-7 · Cited by 92
Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis
Su, X., Xu, B., Yan, B., Qiao, X., & Wang, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187550 · Cited by 91
Hui, J. Y., Choi, J. W. J., Mount, D. B., Zhu, Y., Zhang, Y., & Choi, H. K. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3769 · Cited by 90
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
Kielstein, J. T., Pontremoli, R., & Burnier, M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01116-3 · Cited by 88
Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
Petreski, T., Ekart, R., Hojs, R., & Bevc, S. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1822185 · Cited by 87
Hughes, K., Major, T. J., de Zoysa, J., Dalbeth, N., & Merriman, T. R. (2013) · Kidney International · doi:10.1038/ki.2013.353 · Cited by 86
Oikonen, M., Wendelin‐Saarenhovi, M., Lyytikäinen, L., Siitonen, N., Loo, B.-M., Jula, A., Seppälä, I., Saarikoski, L. A., Lehtimäki, T. J., Hutri‐Kähönen, N., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.036 · Cited by 85
Chen, Q., Wang, Z., Zhou, J., Chen, Z., Li, Y., Li, S., Zhao, H., Badve, S. V., & Lv, J. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05190420 · Cited by 83
The Role of Uric Acid in Acute Kidney Injury
Ejaz, A. A., Johnson, R. J., Shimada, M., Mohandas, R., Alquadan, K. F., Beaver, T. M., Lapsia, V., & Dass, B. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000499939 · Cited by 81
New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
Dekkers, C. C. J., Gansevoort, R. T., & Heerspink, H. J. L. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0992-6 · Cited by 80
Effect of Fenofibrate on Uric Acid Metabolism and Urate Transporter 1
Uetake, D., Ohno, I., Ichida, K., Yamaguchi, Y., Saikawa, H., Endou, H., & Hosoya, T. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2597 · Cited by 73
Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy
Miller, S. G., Hafen, P. S., & Brault, J. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010088 · Cited by 71
Lin, T.-C., Hung, L., Chen, Y.-C., Lo, W., Lin, C. H., Tam, K., & Wu, M. (2019) · Medicine · doi:10.1097/md.0000000000016311 · Cited by 68
Nakagawa, T., Sánchez‐Lozada, L. G., Andrés-Hernando, A., Kojima, H., Kasahara, M., Rodríguez‐Iturbe, B., Bjornstad, P., Lanaspa, M. A., & Johnson, R. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694457 · Cited by 61
The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function
Bove, M., Cicero, A. F. G., & Borghi, C. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0793-3 · Cited by 58
Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis
Luo, Q., Xia, X., Li, B., Lin, Z., Yu, X., & Huang, F. (2019) · BMC Nephrology · doi:10.1186/s12882-018-1143-7 · Cited by 58
The specific impact of uremic toxins upon cognitive domains: a review
Franco, Á. D. O., Starosta, R. T., & Roriz‐Cruz, M. (2018) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0033 · Cited by 55
Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease
Shaffner, J., Chen, B., Malhotra, D. K., Dworkin, L. D., & Gong, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.749010 · Cited by 52
Wong, K., Briddon, S. J., Holliday, N. D., & Kerr, I. D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.002 · Cited by 51
Rana, P., Aleo, M. D., Wen, X., & Kogut, S. J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.028 · Cited by 51
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
Heda, R. P., Yazawa, M., Shi, M. Y., Bhaskaran, M. C., Aloor, F. Z., Thuluvath, P. J., & Satapathy, S. K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i17.1864 · Cited by 50
Mallamaci, F., Testa, A., Leonardis, D., Tripepi, R., Pisano, A., Spoto, B., Sanguedolce, M. C., Parlongo, R. M., Tripepi, G. L., & Zoccali, C. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000224 · Cited by 49
Association of Uric Acid Genetic Risk Score With Blood Pressure: The Rotterdam Study
Sedaghat, S., Pazoki, R., Uitterlinden, A. G., Albert Hofman, D., Stricker, B. H. C., Ikram, M. A., Franco, O. H., & Dehghan, A. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03757 · Cited by 44
Pharmacologic effects of nicotinic acid on human purine metabolism.
Gershon, S. L., & Fox, I. H. (1974) · PubMed · Cited by 41
Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study
Moccia, M., Lanzillo, R., Costabile, T., Russo, C. V., Carotenuto, A., Sasso, G., Postiglione, E., Picione, C. D. L., Vastola, M., Maniscalco, G. T., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7666-y · Cited by 39
Viggiano, D., Gigliotti, G., Vallone, G., Giammarino, A., Nigro, M., & Capasso, G. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000489145 · Cited by 39
Takata, T., & Isomoto, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094374 · Cited by 39
Metabolic syndrome, serum uric acid and renal risk in patients with T2D
Viazzi, F. C., Piscitelli, P. A., Giorda, C. B., Ceriello, A., Genovese, S., Russo, G. T., Guida, P., Fioretto, P., Cosmo, S. D., Pontremoli, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176058 · Cited by 34
Allopurinol Against Progression of Chronic Kidney Disease.
Golmohammadi, S., Almasi, A., Manouchehri, M. E., Omrani, H., & Zandkarimi, M. R. (2017) · Iranian Journal of Kidney Diseases · Cited by 33
Uric acid and risk of diabetic kidney disease
Mauer, M. S., & Doria, A. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00796-z · Cited by 32
Zhang, X., Wan, D., Yang, G., Peng, Q., & Wang, X. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02318-8 · Cited by 30
Novak, S., Melkonian, A. K., Patel, P., Kleinman, N. L., Joseph‐Ridge, N., & Brook, R. A. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167651 · Cited by 25
Ma, J., Han, R., Cui, T., Yang, C., & Wang, S. (2022) · Medicine · doi:10.1097/md.0000000000028442 · Cited by 25
Hsu, Y. O., Wu, I., Chang, S., Lee, C., Tsai, C., Lin, C., Lin, W., Huang, Y., Wu, C., Kuo, G. C., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1697 · Cited by 24
Zhou, Y. L., You, H., Zhang, A., Jiang, X., Pu, Z., Xu, G., & Zhao, M. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8812 · Cited by 20
Flisiński, M., Brymora, A., Skoczylas-Makowska, N., Stefańska, A., & Manitius, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010203 · Cited by 20
Doğru, S., Yaşar, E., & Yeşilkaya, A. (2021) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2021.1931320 · Cited by 18
Chino, Y., Kuwabara, M., & Hisatome, I. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1970 · Cited by 17
Baer, P. C., Koch, B., Freitag, J., Schubert, R., & Geiger, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020391 · Cited by 16
Biochemical and Metabolic Effects of Very-Low-Salt Diets
Egan, B. M., & Lackland, D. T. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40832-8 · Cited by 13
Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone
Niu, S., Hung, C., Lin, H. Y., Kuo, I., Huang, J., He, J.-S., Wen, Z., Liang, P., Chiu, Y., Chang, J., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010028 · Cited by 11
Effects of uric acid-lowering therapy in patients with essential arterial hypertension
Gruszka, K., Drożdż, T., Wojciechowska, W., Jankowski, P., Terlecki, M., Bijak, M., Hering, D., Bilo, G., Drożdż, D., & Rajzer, M. (2022) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000578 · Cited by 10
Association Between Dietary Intake and Serum Uric Acid Levels in Kidney Transplant Patients
Limirio, L. S., Santos, H. O., dos Reis, A. S., et al. (2021) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2020.11.009 · Cited by 8
Cited by
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Gao, Y., Li, C., Li, J., Duan, M., Li, X., Zhao, L., Wu, Y., & Gu, S. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1498540 · Cited by 9
Metadata
- Authors
- Gherghina, M.-E., Peride, I., Tiglis, M., Neagu, T. P., Niculae, A., & Checherita, I. A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-16
- Volume
- 23
- Issue
- 6
- Pages
- 3188
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4221024918
- Cited by
- 501
- References
- 111
- FWCI
- 48.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.